Status:
COMPLETED
A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Obesity
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
This is a 1-year study to assess the safety, tolerability, and efficacy of an investigational drug in obese patients after a very low calorie diet.
Eligibility Criteria
Inclusion
- Obese men and nonpregnant women between the ages of 18 and 65 years with a body mass index (height to weight ratio) as required by the study.
Exclusion
- Patients with uncontrolled high blood pressure and/or diabetes mellitus (high blood sugar)
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2005
Estimated Enrollment :
359 Patients enrolled
Trial Details
Trial ID
NCT00092872
Start Date
November 1 2003
End Date
February 1 2005
Last Update
January 30 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.